國立虎尾科技大學 |

Applications of Ultrasound-Targeted Microbubble Cavitation with Sodium Nitrite and Nitro-Alkenes.

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Applications of Ultrasound-Targeted Microbubble Cavitation with Sodium Nitrite and Nitro-Alkenes./
作者:	Yu, Gary Z.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2020,
面頁冊數:	231 p.
附註:	Source: Dissertations Abstracts International, Volume: 83-05, Section: B.
Contained By:	Dissertations Abstracts International83-05B.
標題:	Physiology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28808960
ISBN:	9798494446084

Applications of Ultrasound-Targeted Microbubble Cavitation with Sodium Nitrite and Nitro-Alkenes.
Yu, Gary Z.

Applications of Ultrasound-Targeted Microbubble Cavitation with Sodium Nitrite and Nitro-Alkenes. - Ann Arbor : ProQuest Dissertations & Theses, 2020 - 231 p.

Source: Dissertations Abstracts International, Volume: 83-05, Section: B.

Thesis (Ph.D.)--University of Pittsburgh, 2020.

This item must not be sold to any third party vendors.

Microvascular obstruction is a common repercussion of percutaneous coronary intervention in treating acute myocardial infarction, and results from a combination of downstream microembolization, ischemia-reperfusion injury, and inflammation. Ultrasound-targeted microbubble cavitation (UTMC) uses external therapeutic ultrasound pulsation to target intravascularly infused microbubble contrast agents to produce shear stresses which mechanically disrupt obstructing microemboli. This work aims to enhance the therapeutic effects of UTMC through synergistic co-administration of nitrite for enhancement of perfusion and nitric oxide bioavailability (Aim 1) and development of a novel microbubble agent using nitro-alkenes for therapeutic reduction of inflammation after ischemia-reperfusion injury (Aim 2).For characterization and optimization of nitrite co-therapy with UTMC, a rat gastrocnemius model was used with contrast-enhanced ultrasound imaging. A nitric oxide porphyrinic membrane catheter probe was inserted into the treatment site for real-time measurement of nitric oxide concentration changes. In addition to nitrite co-therapy, effects of administering an endothelial nitric oxide synthase inhibitor as well as varying microbubble concentration and therapeutic ultrasound pressure were studied. Results showed that UTMC and nitrite demonstrated positive synergy for enhancing nitric oxide concentration and perfusion which depended on functional endothelial nitric oxide synthase.After a novel nitro-alkene microbubble agent was synthesized and characterized, it was applied in both healthy and ischemia-reperfusion injury rat gastrocnemius models. Tissue samples were collected after treatment for quantification of nitro-alkene delivery, changes in inflammatory gene expression, and contrast-enhanced ultrasound imaging was used to quantify changes in hindlimb perfusion after treatment. Results showed that incorporation of the nitro-alkene into a microbubble formulation with UTMC greatly enhanced targeted tissue delivery of the nitro-alkene compared to co-infusion with standard microbubbles and systemic infusion alone. In addition, nitro-alkene microbubble UTMC resulted in greatly enhanced perfusion as well as decreases in inflammatory gene expression.In all, both of these applications of enhancing UTMC therapy demonstrate significant mechanistic interactions with endogenous nitric oxide metabolism and may serve to enhance nitric oxide bioavailability through different pathways. They may also improve the relevance of UTMC in treating the biological sequelae of microvascular obstruction without compromising its mechanical function in disrupting microemboli.

ISBN: 9798494446084Subjects--Topical Terms:

673386
Physiology.

Applications of Ultrasound-Targeted Microbubble Cavitation with Sodium Nitrite and Nitro-Alkenes.
LDR:04018nam a2200445 4500 001 1067265
005 20220823142332.5
008 221020s2020 ||||||||||||||||| ||eng d
020 $a 9798494446084
035 $a (MiAaPQ)AAI28808960
035 $a (MiAaPQ)Pittsburgh38533
035 $a AAI28808960
040 $a MiAaPQ $c MiAaPQ
100 1 $a Yu, Gary Z. $3 1372770
245 1 0 $a Applications of Ultrasound-Targeted Microbubble Cavitation with Sodium Nitrite and Nitro-Alkenes.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2020
300 $a 231 p.
500 $a Source: Dissertations Abstracts International, Volume: 83-05, Section: B.
500 $a Advisor: Kim, Kang;Aizenstein, Howard;Borovetz, Harvey;Shroff, Sanjeev;Pacella, John.
502 $a Thesis (Ph.D.)--University of Pittsburgh, 2020.
506 $a This item must not be sold to any third party vendors.
520 $a Microvascular obstruction is a common repercussion of percutaneous coronary intervention in treating acute myocardial infarction, and results from a combination of downstream microembolization, ischemia-reperfusion injury, and inflammation. Ultrasound-targeted microbubble cavitation (UTMC) uses external therapeutic ultrasound pulsation to target intravascularly infused microbubble contrast agents to produce shear stresses which mechanically disrupt obstructing microemboli. This work aims to enhance the therapeutic effects of UTMC through synergistic co-administration of nitrite for enhancement of perfusion and nitric oxide bioavailability (Aim 1) and development of a novel microbubble agent using nitro-alkenes for therapeutic reduction of inflammation after ischemia-reperfusion injury (Aim 2).For characterization and optimization of nitrite co-therapy with UTMC, a rat gastrocnemius model was used with contrast-enhanced ultrasound imaging. A nitric oxide porphyrinic membrane catheter probe was inserted into the treatment site for real-time measurement of nitric oxide concentration changes. In addition to nitrite co-therapy, effects of administering an endothelial nitric oxide synthase inhibitor as well as varying microbubble concentration and therapeutic ultrasound pressure were studied. Results showed that UTMC and nitrite demonstrated positive synergy for enhancing nitric oxide concentration and perfusion which depended on functional endothelial nitric oxide synthase.After a novel nitro-alkene microbubble agent was synthesized and characterized, it was applied in both healthy and ischemia-reperfusion injury rat gastrocnemius models. Tissue samples were collected after treatment for quantification of nitro-alkene delivery, changes in inflammatory gene expression, and contrast-enhanced ultrasound imaging was used to quantify changes in hindlimb perfusion after treatment. Results showed that incorporation of the nitro-alkene into a microbubble formulation with UTMC greatly enhanced targeted tissue delivery of the nitro-alkene compared to co-infusion with standard microbubbles and systemic infusion alone. In addition, nitro-alkene microbubble UTMC resulted in greatly enhanced perfusion as well as decreases in inflammatory gene expression.In all, both of these applications of enhancing UTMC therapy demonstrate significant mechanistic interactions with endogenous nitric oxide metabolism and may serve to enhance nitric oxide bioavailability through different pathways. They may also improve the relevance of UTMC in treating the biological sequelae of microvascular obstruction without compromising its mechanical function in disrupting microemboli.
590 $a School code: 0178.
650 4 $a Physiology. $3 673386
650 4 $a Clinical medicine. $3 673808
650 4 $a Fatty acids. $3 673135
650 4 $a Skin. $3 778396
650 4 $a Energy. $3 784773
650 4 $a Blood. $3 790457
650 4 $a Visualization. $3 574210
650 4 $a Vibration. $3 595749
650 4 $a Drug dosages. $3 1372771
650 4 $a Composite materials. $3 561730
650 4 $a Oxidative stress. $3 582757
650 4 $a Propagation. $3 1372600
650 4 $a Cavitation. $3 672794
650 4 $a Gene expression. $3 581931
650 4 $a Lithotripsy. $3 1372772
650 4 $a Design. $3 595500
650 4 $a Travel. $3 790152
650 4 $a Arrays. $3 1372585
650 4 $a Contrast agents. $3 1372773
650 4 $a Acoustics. $3 670692
650 4 $a Ischemia. $3 792106
650 4 $a Ultrasonic imaging. $3 798593
650 4 $a Human body. $3 786003
650 4 $a Bioinformatics. $3 583857
650 4 $a Biology. $3 599573
650 4 $a Medical imaging. $3 1180167
650 4 $a Genetics. $3 578972
650 4 $a Materials science. $3 557839
650 4 $a Medicine. $3 644133
650 4 $a Morphology. $3 1183868
650 4 $a Physics. $3 564049
650 4 $a Recreation. $3 559433
690 $a 0791
690 $a 0389
690 $a 0986
690 $a 0719
690 $a 0715
690 $a 0306
690 $a 0574
690 $a 0369
690 $a 0794
690 $a 0564
690 $a 0287
690 $a 0605
690 $a 0814
710 2 $a University of Pittsburgh. $3 1178873
773 0 $t Dissertations Abstracts International $g 83-05B.
790 $a 0178
791 $a Ph.D.
792 $a 2020
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28808960